|
MAP2K1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6489999083168E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.41879841208947E-11 |
| Normal-vs-Stage2 |
1.282170E-03 |
| Normal-vs-Stage3 |
7.50380000000828E-05 |
| Normal-vs-Stage4 |
5.881800E-01 |
| Stage1-vs-Stage2 |
2.731600E-01 |
| Stage1-vs-Stage3 |
1.466570E-01 |
| Stage1-vs-Stage4 |
2.650000E-01 |
| Stage2-vs-Stage3 |
8.994200E-01 |
| Stage2-vs-Stage4 |
4.660200E-01 |
| Stage3-vs-Stage4 |
4.865800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.19689846711913E-11 |
| Normal-vs-AfricanAmerican |
2.78379999996137E-06 |
| Normal-vs-Asian |
2.788600E-01 |
| Caucasian-vs-AfricanAmerican |
2.101200E-01 |
| Caucasian-vs-Asian |
2.846000E-01 |
| AfricanAmerican-vs-Asian |
5.882800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43516318221282E-12 |
| Normal-vs-Female |
7.963900E-03 |
| Male-vs-Female |
6.26089999999913E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.193000E-04 |
| Normal-vs-Extreme_Weight |
1.9453327837482E-12 |
| Normal-vs-Obese |
1.70750000028086E-07 |
| Normal-vs-Extreme_Obese |
3.96800000002084E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.030550E-01 |
| Normal_Weight-vs-Obese |
8.486400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.296800E-01 |
| Extreme_Weight-vs-Obese |
2.672100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.738800E-01 |
| Obese-vs-Extreme_Obese |
2.093600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.702300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64760000087583E-08 |
| Normal-vs-Age(61-80Yrs) |
2.9300006865185E-11 |
| Normal-vs-Age(81-100Yrs) |
3.03739999818475E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.065200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.910100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.392000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.486220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.433900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.997390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66375810298314E-12 |
| Normal-VS-Type2 PRCC |
6.28640000055469E-08 |
| Normal-VS-KIRP CIMP |
2.704800E-01 |
| Normal-VS-Unclassified PRCC |
6.17700000038468E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.526590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.082080E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.215900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.054200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.234200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.438000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.22300003036725E-09 |
| Normal-vs-N1 |
2.001800E-03 |
| Normal-vs-N2 |
8.578600E-01 |
| N0-vs-N1 |
5.992000E-02 |
| N0-vs-N2 |
4.300800E-01 |
| N1-vs-N2 |
5.697800E-01 |
|
|
